Review article: strategies for the management of chronic unremitting ulcerative colitis

943b Induction Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial

(2015) B.G. Feagan et al.   GASTROENTEROLOGY

943d A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SC

(2015) W.J. Sandborn et al.   GASTROENTEROLOGY

Ileal Pouch Anal Anastomosis

(2013) Victor Warren Fazio et al.   ANNALS OF SURGERY

Evaluation of long-term function, complications, quality of life and health status after restorative proctocolectomy with ileo neo rectal and with ileal pouch anal anastomosis for ulcerative colitis

(2013) J. T. Heikens et al.   Colorectal Disease

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

(2013) Simon P L Travis et al.   GUT

Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients

(2012) K. J. Schmidt et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2

(2012) W. J. Sandborn et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery

(2012) Z. Yang et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study

(2012) William J. Sandborn et al.   GASTROENTEROLOGY

Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease

(2012) Matti Waterman et al.   GUT

Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol

(2012) Melissa A. Smith et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

(2012) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

(2011) Khurram J Khan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis

(2011) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease

(2011) Laurent Peyrin–Biroulet et al.   GASTROENTEROLOGY

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

(2011) Jean Frédéric Colombel et al.   GASTROENTEROLOGY

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

(2011) William J. Sandborn et al.   GASTROENTEROLOGY

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

(2011) Natalie A. Molodecky et al.   GASTROENTEROLOGY

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

(2011) W. Reinisch et al.   GUT

Guidelines for the management of inflammatory bowel disease in adults

(2011) C. Mowat et al.   GUT

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

(2011) Haruhiko Ogata et al.   INFLAMMATORY BOWEL DISEASES

Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study

(2011) Asit Parikh et al.   INFLAMMATORY BOWEL DISEASES

Review article: improving adherence to medication in patients with inflammatory bowel disease

(2010) A. ROBINSON   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis

(2010) S. Thanaraj et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Infliximab for refractory ulcerative proctitis

(2010) G. BOUGUEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: the costs of ulcerative colitis in Western countries

(2010) R. D. COHEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort

(2010) N. Gies et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy and Hospitalization

(2010) Abderrahim Oussalah et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

(2010) Antonio Tursi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Disease Activity, ANCA and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis

(2010) Matthias Jürgens et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Mesalamine Suppositories 1 g at Bedtime and 500 mg Twice Daily in Patients with Active Mild-to-Moderate Ulcerative Proctitis

(2010) Mark Lamet   DIGESTIVE DISEASES AND SCIENCES

Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis

(2010) Tilo Andus et al.   INFLAMMATORY BOWEL DISEASES

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease

(2010) Melissa L. Haines et al.   INFLAMMATORY BOWEL DISEASES

Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine

(2009) M. WAHED et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis

(2009) Z. YANG et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Distribution and Manifestations of Inflammatory Bowel Disease in Asians, Hispanics and African Americans: A Systematic Review

(2009) Jason K Hou et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Appendicectomy as a Therapy for Ulcerative Proctitis

(2009) Terry Dorcen Bolin et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Long-term failure and function after restorative proctocolectomy - a multi-centre study of patients from the UK national ileal pouch registry

(2009) P. P. Tekkis et al.   Colorectal Disease

Surgery in Ulcerative Colitis: Indication and Timing

(2009) Peter Andersson et al.   DIGESTIVE DISEASES

The Impact of Ulcerative Colitis on Patients’ Lives Compared to Other Chronic Diseases: A Patient Survey

(2009) David T. Rubin et al.   DIGESTIVE DISEASES AND SCIENCES

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis

(2009) C H Seow et al.   GUT

Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis

(2009) M. Ferrante et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

(2009) Javier P. Gisbert et al.   INFLAMMATORY BOWEL DISEASES

Rectal tacrolimus in the treatment of resistant ulcerative proctitis

(2008) I. C. LAWRANCE et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis

(2008) S. YAMAMOTO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Colectomy and the Incidence of Postsurgical Complications Among Ulcerative Colitis Patients With Private Health Insurance in the United States

(2008) Edward V. Loftus et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical course of ulcerative colitis

(2008) M. Cottone et al.   DIGESTIVE AND LIVER DISEASE

Comparison of Mesalazine and Balsalazide in Induction and Maintenance of Remission in Patients with Ulcerative Colitis: A Meta-Analysis

(2008) Roja Rahimi et al.   DIGESTIVE DISEASES AND SCIENCES

Impact of Hospital Volume on Postoperative Morbidity and Mortality Following a Colectomy for Ulcerative Colitis

(2008) Gilaad G. Kaplan et al.   GASTROENTEROLOGY

A Randomized, Double-Blind, Sham-Controlled Study of Granulocyte/Monocyte Apheresis for Active Ulcerative Colitis

(2008) Bruce E. Sands et al.   GASTROENTEROLOGY

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

(2008) W Kruis et al.   GUT

Clostridium difficile and inflammatory bowel disease

(2008) Mazen Issa et al.   INFLAMMATORY BOWEL DISEASES

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

(2008) Inger Camilla Solberg et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY